|
業務類別
|
Biotechnology |
|
業務概覽
|
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs). |
| 公司地址
| 11611 North Meridian Street, Suite 330, Carmel, IN, USA, 46032 |
| 電話號碼
| +1 812 689-0791 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.neuraxis.com |
| 員工數量
| 24 |
| Mr. Brian Carrico |
President, Chief Executive Officer and Director |
美元 345.10K |
28/04/2026 |
| Dr. Adrian Miranda |
Chief Medical Officer and Senior Vice President, Science and Technology |
美元 300.00K |
28/04/2026 |
| Dr. Thomas Carrico |
Chief Regulatory Officer, Compliance Officer and Privacy Officer |
美元 300.00K |
28/04/2026 |
| Mr. Timothy H. Henrichs |
Chief Financial Officer and Principal Accounting Officer |
美元 327.34K |
28/04/2026 |
|
|
| Ms. Kristin A. Ferge |
Independent Director |
28/04/2026 |
| Dr. Gilad Aharon, PhD |
Independent Director |
28/04/2026 |
| Mr. Brian Carrico |
President, Chief Executive Officer and Director |
28/04/2026 |
| Dr. Christopher Robin Brown |
Director |
28/04/2026 |
| Mr. Bradley Mitch Watkins |
Chairman of the Board |
28/04/2026 |
| Ms. Beth Keyser |
Independent Director |
28/04/2026 |
|
|
|
|
